Skip to main content
. 2022 Oct 7;12:966920. doi: 10.3389/fonc.2022.966920

Figure 10.

Figure 10

Investigation of immune cell infiltration and the tumor environment (TME). (A, B) Immune cell infiltration and immune-related function activation in the low- and high-risk group of AML patients. (C-E) Comparison of immune-related scores between low- and high-risk groups. (F) Twenty-three differentially expressed checkpoints between low- and high-risk groups. *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001.